Published in


Pfizer COVID-19 Pill 89% Effective in Reducing Hospitalization and Death

If the FDA grants emergency use authorization for the drug, it could become available in the U.S. by next year

Pfizer Logo, Public domain, via Wikimedia Commons; Pills, Photo by Hal Gatewood on Unsplash

Pfizer has been conducting a randomized, double-blind study of their antiviral pill to a cohort of 1,881 non-hospitalized adult patients with COVID-19. They…




A Medika Life Publication for the Medical Community

Recommended from Medium

Pandemic resilient careers — The jobs that got busier during covid 19

Covid-19 Just Maybe The biggest TurnPoint In History!

The Unfolding of the Coronavirus Pandemic:

Get the Shot

I am tired.

<a href=””>It’s Jobless Thursday!</a>

I Get It…but I don’t Get It…

Hope from the borders

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dr. Zach Zachariah

Dr. Zach Zachariah

Ph.D. chemist with an M.B.A. | Enrolled Agent | Writes on science | economy | taxes | public interest topics | American politics | Indian-Americans | COVID-19

More from Medium

The Radical Act of Giving

Peas, Flame Weeders, and Satan’s Briar Patch

A bowl of peas covered in black powdered inoculant sits in front of a row of planted peas.

The Resurgence of Interest in Anti-Cancer Dendritic Cell Vaccines | Biomedgrid llc